SCHEMBL4636005

SCHEMBL4636005

CC(C)(C)OC(=O)c1c[nH]c(N)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 8/20 0.37
GABRG2 P18507 8/20 0.37
GABRB3 P28472 8/20 0.37
GABRA3 P34903 8/20 0.37
GABRA2 P47869 8/20 0.37
GABRA5 P31644 7/20 0.37
GABRA6 Q16445 6/20 0.37
GABRA4 P48169 5/20 0.37
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRB1 P18505 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRE P78334 1/20 0.37
GABRG1 Q8N1C3 1/20 0.37
GABRG3 Q99928 1/20 0.37
GABRQ Q9UN88 1/20 0.37
HPGDS O60760 1/20 0.35
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL159836 0.81 GABRA1 (0.39) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL28868370 0.81 GABRA1 (0.38) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL4740436 0.79 GABRG2 (0.41) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL3794190 0.79 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL10067534 0.77 ALDH1A1 (0.38) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL6858146 0.76 GABRA1 (0.34) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL1407854 0.76 CYP1A2 (0.51) KDM4EALDH1A1GAAMAPTHPGD
SCHEMBL4747477 0.76 GABRA1 (0.35) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL10716727 0.75 GABRA1 (0.33) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL5524714 0.74 HPGDS (0.34) GABRA1GABRG2GABRB3GABRA3GABRA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931662-A1 PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY AstraZeneca AB (SE) 2008-06-18 EP disclosed
WO-2007031745-A1 PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY ASTRAZENECA AB (SE) 2007-03-22 WO disclosed